About
In the U.S., over 30 million people are treated for back pain every year…
Articles by Gaetano
Activity
-
I really love the direction that expandable technology is going. There’s nothing better than putting an “ALIF cage” in a TLIF procedure. What’s the…
I really love the direction that expandable technology is going. There’s nothing better than putting an “ALIF cage” in a TLIF procedure. What’s the…
Liked by Gaetano Scuderi, MD
-
MAJOR PHASE 1 UPDATE! Joey Bose Cytonics Corporation #Cytonics #drugdevelopment #clinicaltrials #arthritis
MAJOR PHASE 1 UPDATE! Joey Bose Cytonics Corporation #Cytonics #drugdevelopment #clinicaltrials #arthritis
Shared by Gaetano Scuderi, MD
-
𝗤𝗨𝗜𝗖𝗞 𝗧𝗜𝗣𝗦 𝗧𝗢 𝗥𝗘𝗠𝗘𝗠𝗕𝗘𝗥 𝗔𝗡𝗧𝗜𝗕𝗜𝗢𝗧𝗜𝗖𝗦 1. Penicillins - Examples: Penicillin G, Penicillin V, Amoxicillin, Ampicillin…
𝗤𝗨𝗜𝗖𝗞 𝗧𝗜𝗣𝗦 𝗧𝗢 𝗥𝗘𝗠𝗘𝗠𝗕𝗘𝗥 𝗔𝗡𝗧𝗜𝗕𝗜𝗢𝗧𝗜𝗖𝗦 1. Penicillins - Examples: Penicillin G, Penicillin V, Amoxicillin, Ampicillin…
Liked by Gaetano Scuderi, MD
Experience & Education
Honors & Awards
-
510k
FDA
FDA approval 510K: BK 130060: Autologous Platelet Integrated Concentration ("APIC") System 1/17/14.
More activity by Gaetano
-
🎉 Milestone Achieved: Reflecting on 2024 at Cytonics This year has been nothing short of transformative for Cytonics, and we couldn’t have done it…
🎉 Milestone Achieved: Reflecting on 2024 at Cytonics This year has been nothing short of transformative for Cytonics, and we couldn’t have done it…
Shared by Gaetano Scuderi, MD
-
Wow... Tremendous accomplishment for our team of "upstart" biotech players. We are on track to hit all of our R&D milestones in 2025. More…
Wow... Tremendous accomplishment for our team of "upstart" biotech players. We are on track to hit all of our R&D milestones in 2025. More…
Shared by Gaetano Scuderi, MD
-
https://lnkd.in/ddtMcnDE This our latest published peer-reviewed study showing that Traumatic Brain Injury (TBI) symptoms are improved by 50% after…
https://lnkd.in/ddtMcnDE This our latest published peer-reviewed study showing that Traumatic Brain Injury (TBI) symptoms are improved by 50% after…
Liked by Gaetano Scuderi, MD
-
Very pleased to announce that Cytonics Corporation is barreling through our Phase 1 study of CYT-108, our novel biologic therapy based on the…
Very pleased to announce that Cytonics Corporation is barreling through our Phase 1 study of CYT-108, our novel biologic therapy based on the…
Liked by Gaetano Scuderi, MD
-
Very pleased to announce that Cytonics Corporation is barreling through our Phase 1 study of CYT-108, our novel biologic therapy based on the…
Very pleased to announce that Cytonics Corporation is barreling through our Phase 1 study of CYT-108, our novel biologic therapy based on the…
Shared by Gaetano Scuderi, MD
Other similar profiles
-
Kirit A. Bhatt, MD, FACS
Connect -
Michael Sherling
Connect -
Anthony Capasso
Chief Medical Officer for ThinMD Med Spa
Connect -
Brian Fengler, MD
Connect -
David Leachman, MD MBA FASA FACHE
Connect -
Gary Wörtz, MD
Connect -
Adam Wolfberg
Connect -
Jeremy Slater
Connect -
Geoffrey Rutledge
Connect -
Karl Kochendorfer, MD, FAAFP, FAMIA
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More